Trial record 1 of 3 for:    TH-CR-404
Previous Study | Return to List | Next Study

Study of the Safety and Efficacy of TH-302 in Combination With Gemcitabine Compared With Gemcitabine Alone in Previously Untreated Patients With Pancreatic Adenocarcinoma

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
PRA Health Sciences
Information provided by:
Threshold Pharmaceuticals
ClinicalTrials.gov Identifier:
NCT01144455
First received: June 11, 2010
Last updated: July 16, 2013
Last verified: July 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: January 2014
  Estimated Primary Completion Date: August 2013 (Final data collection date for primary outcome measure)